Weiter zum Inhalt
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Erweitert
  • Inability to Tolerate Standard...
  • Zitieren
  • SMS versenden
  • Als E-Mail versenden
  • Drucken
  • Datensatz exportieren
    • Exportieren nach RefWorks
    • Exportieren nach EndNoteWeb
    • Exportieren nach EndNote
  • Persistenter Link
Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial

Weitere Versionen anzeigen (2)
Bibliographische Detailangaben
Hauptverfasser: Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A
Format: Conference item
Veröffentlicht: 2010
  • Exemplare
  • Beschreibung
  • Weitere Versionen (2)
  • Ähnliche Einträge
  • Internformat
Treffer 1 - 2 von 2
Alle Versionen (3)
Search Result 1
Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial von Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

Veröffentlicht 2010
Conference item
Search Result 2
Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial

Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial von Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

Veröffentlicht 2010
Conference item
Alle Versionen (3)

Ähnliche Einträge

  • Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial
    von: Sive, J, et al.
    Veröffentlicht: (2010)
  • Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial
    von: Sive, J, et al.
    Veröffentlicht: (2010)
  • Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
    von: Sive, J, et al.
    Veröffentlicht: (2012)
  • Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
    von: Fielding, A, et al.
    Veröffentlicht: (2007)
  • Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial
    von: Fielding, A, et al.
    Veröffentlicht: (2010)

Suchoptionen

  • Suchhistorie
  • Erweiterte Suche

Weitere Suchoptionen

  • Katalog durchstöbern
  • Alphabetisch durchstöbern
  • Inhalte erkunden
  • Semesterapparat
  • Neuerscheinungen

Hilfe

  • Suchtipps
  • Fachauskunft der Bibliothek
  • Häufig gestellte Fragen